Your browser doesn't support javascript.
loading
Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
Muruato, Antonio; Vu, Michelle N; Johnson, Bryan A; Davis-Gardner, Meredith E; Vanderheiden, Abigail; Lokugmage, Kumari; Schindewolf, Craig; Crocquet-Valdes, Patricia A; Langsjoen, Rose M; Plante, Jessica A; Plante, Kenneth S; Weaver, Scott C; Debbink, Kari; Routh, Andrew L; Walker, David; Suthar, Mehul S; Xie, Xuping; Shi, Pei-Yong; Xie, Xuping; Menachery, Vineet D.
Afiliación
  • Muruato A; Departments of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Vu MN; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Johnson BA; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Davis-Gardner ME; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Vanderheiden A; Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Lokugmage K; Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Schindewolf C; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Crocquet-Valdes PA; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Langsjoen RM; Pathology, University of Texas Medical Branch, Galveston, TX, USA.
  • Plante JA; Departments of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Plante KS; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Weaver SC; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.
  • Debbink K; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Routh AL; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.
  • Walker D; Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Suthar MS; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
  • Xie X; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.
  • Shi PY; Department of Natural Science, Bowie State University, Bowie, MD, USA.
  • Xie X; Departments of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Menachery VD; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
bioRxiv ; 2021 May 04.
Article en En | MEDLINE | ID: mdl-33972939
ABSTRACT
The emergence of SARS-CoV-2 has resulted in a worldwide pandemic causing significant damage to public health and the economy. Efforts to understand the mechanisms of COVID-19 disease have been hampered by the lack of robust mouse models. To overcome this barrier, we utilized a reverse genetic system to generate a mouse-adapted strain of SARS-CoV-2. Incorporating key mutations found in SARSCoV-2 variants, this model recapitulates critical elements of human infection including viral replication in the lung, immune cell infiltration, and significant in vivo disease. Importantly, mouse-adaptation of SARS-CoV-2 does not impair replication in human airway cells and maintains antigenicity similar to human SARS-CoV-2 strains. Utilizing this model, we demonstrate that SARS-CoV-2 infected mice are protected from lethal challenge with the original SARS-CoV, suggesting immunity from heterologous CoV strains. Together, the results highlight the utility of this mouse model for further study of SARS-CoV-2 infection and disease.